S.Africa suspends use of AstraZeneca vaccine due to its limited protection

South Africa will suspend use of the AstraZeneca vaccine in its immunisation program while scientists advise on the best way to proceed, Health Minister Zweli Mkhize said on Sunday.
Mkhize was speaking after trial data showed the AstraZeneca vaccine offered only limited protection against mild disease caused by the 501Y.V2 coronavirus variant first identified in South Africa.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy